- Detection of non-small cell lung cancer marker CYFRA21-1 via Mxene-based immunoelectrochemical sensor
Dong Li et al, 2023, International Journal of Electrochemical Science CrossRef - Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study
Xiongwen Yang et al, 2023, Therapeutic Advances in Medical Oncology CrossRef - Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update
Inga Trulson et al, 2024, Tumor Biology CrossRef - An Approach to Evaluate Blurriness in Retinal Images with Vitreous Opacity for Cataract Diagnosis
Li Xiong et al, 2017, Journal of Healthcare Engineering CrossRef - Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis
Stefan Holdenrieder et al, 2017, British Journal of Cancer CrossRef - Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker
Jia Gao et al, 2015, Tumor Biology CrossRef - CYFRA 21-1 is an early predictor of chemotherapeutic effectiveness in advanced nonsmall cell lung cancer
Tongwei Zhao et al, 2016, Medicine CrossRef - Prognostic value of baseline carcinoembryonic antigen and cytokeratin 19 fragment levels in advanced non-small cell lung cancer
Ae Rin Baek et al, 2018, Cancer Biomarkers CrossRef - Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
Jian Huang et al, 2023, BMC Cancer CrossRef - New clinical advances in immunotherapy for the treatment of solid tumours
Valentina A. Zavala et al, 2015, Immunology CrossRef - Increases in Serum CYFRA21-1 Concentration during Successful Treatment with Crizotinib
Shuji Bandoh, 2014, American Journal of Case Reports CrossRef